
NuVasive NUVA
Quarterly report 2023-Q2
added 08-02-2023
NuVasive ROCE Ratio 2011-2026 | NUVA
Annual ROCE Ratio NuVasive
| 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| - | - | - | 7.21 | 6.7 | 8.26 | 7.4 | 8.72 | 5.21 | 3.11 | 4.67 | 3.75 |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 8.72 | 3.11 | 6.12 |
ROCE Ratio of other stocks in the Medical devices industry
| Issuer | ROCE Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
GenMark Diagnostics, Inc.
GNMK
|
-6.16 | - | - | $ 1.77 B | ||
|
Axonics Modulation Technologies
AXNX
|
-11.39 | - | - | $ 3.31 B | ||
|
Lianluo Smart Limited
LLIT
|
-89.32 | - | 24.59 % | $ 44.8 M | ||
|
Aziyo Biologics
AZYO
|
-97.25 | - | 1.37 % | $ 20.5 M | ||
|
Acutus Medical
AFIB
|
1334.24 | - | -26.83 % | $ 2.62 M | ||
|
Zimmer Biomet Holdings
ZBH
|
10.31 | $ 88.57 | -0.65 % | $ 18 B | ||
|
Allied Healthcare Products
AHPI
|
-24.19 | - | 3.58 % | $ 2.21 M | ||
|
Obalon Therapeutics, Inc.
OBLN
|
-191.02 | - | -5.86 % | $ 30.6 M | ||
|
Accuray Incorporated
ARAY
|
9.66 | $ 0.4 | 4.21 % | $ 41.1 M | ||
|
Cardiovascular Systems
CSII
|
-14.35 | - | 0.15 % | $ 844 M | ||
|
Abbott Laboratories
ABT
|
15.45 | $ 103.99 | -0.55 % | $ 181 B | ||
|
Apollo Endosurgery
APEN
|
-96.4 | - | - | $ 475 M | ||
|
Align Technology
ALGN
|
15.77 | $ 166.38 | -6.17 % | $ 12.5 B | ||
|
Avinger
AVGR
|
268.22 | - | -20.74 % | $ 369 K | ||
|
CryoLife, Inc.
CRY
|
0.33 | - | -4.14 % | $ 702 M | ||
|
Alphatec Holdings
ATEC
|
-660.94 | $ 10.93 | -5.12 % | $ 1.64 B | ||
|
AxoGen
AXGN
|
-6.09 | $ 31.28 | -3.01 % | $ 1.44 B | ||
|
CHF Solutions, Inc.
CHFS
|
-804.35 | - | 1.15 % | $ 34.5 M | ||
|
Bruker Corporation
BRKR
|
14.21 | $ 33.72 | -4.58 % | $ 5.02 K | ||
|
BioSig Technologies
BSGM
|
978.11 | - | 37.08 % | $ 85.7 M | ||
|
Boston Scientific Corporation
BSX
|
14.91 | $ 69.17 | -1.43 % | $ 102 B | ||
|
Soliton, Inc.
SOLY
|
-46.49 | - | -1.42 % | $ 435 M | ||
|
Conformis
CFMS
|
-85.42 | - | - | $ 16.4 M | ||
|
Hancock Jaffe Laboratories, Inc.
HJLI
|
-124.26 | - | -1.98 % | $ 98.3 M | ||
|
Itamar Medical Ltd.
ITMR
|
-22.41 | - | 0.03 % | $ 1.58 B | ||
|
ClearPoint Neuro
CLPT
|
-86.24 | $ 9.07 | -3.41 % | $ 257 M | ||
|
CONMED Corporation
CNMD
|
9.93 | $ 34.58 | -5.62 % | $ 1.07 B | ||
|
Misonix, Inc.
MSON
|
-10.4 | - | - | $ 462 M | ||
|
Neovasc
NVCN
|
-344.26 | - | - | $ 111 M | ||
|
Dynatronics Corporation
DYNT
|
-75.2 | - | 14.99 % | $ 929 K | ||
|
Intersect ENT, Inc.
XENT
|
-36.94 | - | - | $ 955 M | ||
|
Electromed
ELMD
|
22.36 | $ 24.55 | 0.41 % | $ 208 M | ||
|
Cytosorbents Corporation
CTSO
|
-151.13 | $ 0.59 | -1.18 % | $ 32.1 M | ||
|
Aethlon Medical
AEMD
|
-182.32 | $ 2.15 | -5.29 % | $ 3.36 M | ||
|
BIOLASE
BIOL
|
7261.94 | - | -13.19 % | $ 166 K | ||
|
Edwards Lifesciences Corporation
EW
|
12.23 | $ 79.34 | -3.36 % | $ 46.4 B | ||
|
Second Sight Medical Products
EYES
|
-175.18 | - | -0.97 % | $ 54.4 M | ||
|
AdaptHealth Corp.
AHCO
|
5.98 | $ 11.2 | -1.84 % | $ 1.51 B | ||
|
OrthoPediatrics Corp.
KIDS
|
-8.49 | $ 15.52 | -5.08 % | $ 364 M | ||
|
Helius Medical Technologies
HSDT
|
-528.85 | $ 1.92 | -4.48 % | $ 1.17 M | ||
|
Invacare Corporation
IVC
|
-99.23 | - | - | $ 24.7 M | ||
|
Inogen
INGN
|
-15.71 | $ 6.19 | -4.77 % | $ 165 M | ||
|
IRIDEX Corporation
IRIX
|
-105.09 | $ 0.99 | -26.67 % | $ 16 M | ||
|
Integer Holdings Corporation
ITGR
|
12.67 | $ 85.33 | -1.73 % | $ 2.96 B | ||
|
Myomo
MYO
|
-126.29 | $ 0.7 | 2.32 % | $ 29.3 M | ||
|
Penumbra
PEN
|
13.26 | $ 335.1 | -0.39 % | $ 13 B | ||
|
LivaNova PLC
LIVN
|
16.62 | $ 61.85 | -2.83 % | $ 3.37 B | ||
|
LENSAR
LNSR
|
-219.35 | $ 6.07 | 9.96 % | $ 69.9 M | ||
|
Inspire Medical Systems
INSP
|
6.52 | $ 50.13 | -0.63 % | $ 1.47 B | ||
|
Medtronic PLC
MDT
|
12.4 | $ 87.14 | 0.21 % | $ 112 B |